Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A randomized, double-blind, placebo-controlled, 4 period incomplete block cross-over, multi-center, multiple dose (7 days) dose-ranging study to assess the efficacy and safety of 4 doses of NVA237 in patients with stable Chronic Obstructive Pulmonary Disease (COPD), compared to seven days treatment with tiotropium (18µg once daily, open label) as an active control https://kusajili.fr:443/Trial/BRxZX4893Um6XvQKjswMTA%24a-randomized-double-blind-placebo-controlled-4-period-incomplete-block-cross-over-multi-center-multiple-dose-7-days-dose-rangin
I have read and accept the terms of use of the site and the Privacy Policy
Send your message